Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 391,000 | 226,451 | -61,286 | -215,975 | -167,870 |
| Depreciation Amortization | 6,336 | 6,579 | -1,981 | -710 | 5,748 |
| Income taxes - deferred | -249,879 | N/A | N/A | N/A | N/A |
| Accounts receivable | -22,718 | -472 | -36,072 | 2,171 | -16,119 |
| Accounts payable and accrued liabilities | -5,289 | -1,351 | 4,797 | 5,870 | -1,617 |
| Other Working Capital | -89,756 | 4,155 | 18,133 | 37,991 | -24,824 |
| Other Operating Activity | 80,142 | -77,643 | 93,111 | 56,618 | 79,022 |
| Operating Cash Flow | $109,836 | $157,719 | $16,702 | $-114,035 | $-125,660 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -692,565 | -505,095 | -357,732 | 73,241 | -69,980 |
| PPE Investments | -4,690 | -523 | -50 | N/A | -1,122 |
| Sale Of Investment | 493,529 | 328,565 | 429,780 | N/A | N/A |
| Other Investing Activity | -98,838 | 146,515 | -40,000 | 0 | 0 |
| Investing Cash Flow | $-302,564 | $-30,538 | $31,998 | $73,241 | $-71,102 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,883 | 6,845 | 25,129 | 8,199 | 18,162 |
| Financing Cash Flow | $49,883 | $6,845 | $25,129 | $8,199 | $18,162 |
| Exchange Rate Effect | 26 | -94 | -18 | 6 | 7 |
| Beginning Cash Position | 328,359 | 194,427 | 120,616 | 153,205 | 331,798 |
| End Cash Position | 185,540 | 328,359 | 194,427 | 120,616 | 153,205 |
| Net Cash Flow | $-142,819 | $133,932 | $73,811 | $-32,589 | $-178,593 |
| Free Cash Flow | |||||
| Operating Cash Flow | 109,836 | 157,719 | 16,702 | -114,035 | -125,660 |
| Capital Expenditure | -4,690 | -523 | -50 | N/A | -1,122 |
| Free Cash Flow | 105,146 | 157,196 | 16,652 | -114,035 | -126,782 |